483 Roundup: Four Drugmakers Cited Over Quality Problems

Drug GMP Report
Four U.S. drug manufacturers were handed Form 483s for quality violations observed at their facilities, such as issues with quality monitoring, facility maintenance and unqualified handling of quality responsibilities.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $200.00